肺癌血管生成抑制物作用机制及应用研究进展
摘要
介绍主要肺癌血管生成抑制物血管抑素、内皮抑素、基质金属蛋白酶抑制剂、白介素 -
出处
《天津药学》
2002年第2期6-8,共3页
Tianjin Pharmacy
参考文献17
-
1Cornelius L A, Nehring LC, Harding E, et al. Matrix metalloproteinases generate angiostatin: effects on Neovascularization. J Immunol, 1998,161(12): 6845
-
2Lucas R, Holmgren L, Garcia I, et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood, 1998,92 ( 12 ):4730
-
3Moser T L, Stack M S, Asplin I, et al. Angiostatin binds ATPsynthase on the surface of human endothelial cells. proc natl Acad sci USA, 1999,96(6):2811
-
4Redlitz A, DaumG, Sage E H. Angiostatin diminishes activation of the mitogen activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells. J Vasc Res, 1999,36(1):28
-
5O'Reilly M S, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88:277
-
6SimBKL, O'ReilyMS, LiangH, etal. Arecombinant human angiostatin protein inhibits experimental primary and metastaic cancer. Cancer Res, 1997,57:1329
-
7Boehm T, O'Reilly M S, Shing Y, et al . Endostatin; an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1999,88(2):277
-
8Dhanabal M,Ramchandran R,Waterm M J, et al. Endostatim induces endothelial cell apotosis. J Biol chem,1999,274(17):11721
-
9Dixelius J, Larsson H, Sasaki T, et al. Endostatin induced tyrosine Kinase signaling through the shb adator protein regulates endothelial cell apoptosis. Blood, 2000, 95(11): 3403
-
10Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.Nature, 1997,390:404
-
1邓永强,邱蔚六,何荣根,林国础.TNP-470抗人涎腺腺样囊性癌裸鼠肺转移作用的实验研究[J].中华口腔医学杂志,2003,38(3):178-178. 被引量：1
-
2夏景林.血管生成抑制物研究进展[J].实用肿瘤杂志,1996,11(5):240-242.
-
3于顺江.抗VEGF肿瘤靶向治疗进展[J].癌症进展,2010,8(2):175-179. 被引量：8
-
4李潇.联合药物治疗结肠直肠癌[J].中国生物化学与分子生物学报,2003,19(6):784-784.
-
5詹仁雅,潘剑威.一氧化氮对肿瘤血管生成的作用[J].中华神经外科疾病研究杂志,2005,4(1):86-87.
-
6宫亮,杨和平.肺癌的抗血管生成基因治疗[J].中国肺癌杂志,2002,5(3):232-234.
-
7综述列题[J].中国癌症防治杂志,1997(2):162-164.
-
8朱江,彭宽嘉,何津春.癌胚抗原在肿瘤中应用研究进展[J].国际检验医学杂志,2015,36(21):3137-3138. 被引量：14
-
9肿瘤免疫与单克隆抗体应用研究进展[J].浙江省医学科学院学报,1991,2(4):22-25.
-
10李洸.肿瘤免疫与单克隆抗体应用研究进展[J].浙江肿瘤通讯,1991(2):53-55.
